Press release
Intravenous Immunoglobulins to Capture 2/5th of the Global Plasma Fractionation Market Share Through 2026
Fact.MR forecasts bullish prospects for the plasma fractionation market. The utilization of immunoglobulins has augmented in the last few years. Plasma-derived immunoglobulins are giving a new narrative to healthcare across a wide range of autoimmune and inflammatory diseases. This widespread applicability is anticipated to leverage market prospects for plasma fractionation, pegged to witness a noteworthy 7% CAGR.Click here to Get Synopsis of the Report – https://www.factmr.com/report/4806/plasma-fractionation-market
In addition, consistent technological innovations for developing efficient and cost-effective procedures for fractioning proteins shall also augment the plasma fractionation market. Therapies such as Ceruloplasmin and IgA are some examples of such innovations. Based on these trends, the plasma fractionation market is anticipated to scale up in the future, expanding 1.5x in the forecast period. (2020-2026)
Key Takeaways from the Plasma Fractionation Market Study:
• By product, intravenous immunoglobulins are poised to maintain their hegemony in the plasma fractionation market. The segment is poised to capture more than 2/5th of the overall market. High incidence of autoimmune diseases shall drive growth within this segment.
• By application, the neurology segment shall leverage almost 2.0x, capturing more than 2/5th of the plasma fractionation market. Rising prevalence of neurological disorders is attributed as an important growth driver for this segment. More than 450 million people worldwide are affected by neurological disorders.
For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4806
• By end-user, hospitals and clinics shall account for a significant chunk of revenue, capturing nearly 70% of the plasma fractionation market. Robust expansion of hospitals as a result of significant investments is set to augment the share of this segment.
• By region, North America shall dominate the plasma fractionation market. Rising prevalence of autoimmune, neurological and hemophilic diseases shall augment market prospects for the region. The North American market shall capture nearly 2/5th of the plasma fractionation market.
• Following North America is the Asia-Pacific, expanding at a healthy CAGR of 8.0%. Prevalence of bleeding and immune disorders have prompted greater utilization of plasma fractionation techniques. Moreover, improving healthcare infrastructure and awareness about plasma fractionation proteins and their use are other growth levers.
• The COVID-19 pandemic is set to generate significant growth opportunities for the plasma fractionation market. Convalescent Plasma (CP) treatment is anticipated to be a key development in this regard.
• Key players such as Octapharma and Grifols are actively engaged in finding potential cures for the novel coronavirus diseases through the CP technique.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806
“Burgeoning technological innovations, combined with widespread usage of immunoglobulins for treating various neurological and autoimmune diseases shall broaden growth prospects. A positive growth trajectory is predicted for the plasma fractionation market during the forecast period,” infers a Fact.MR analyst.
Stakeholders’ Consensus on Novel Offerings to Herald an Era of Profitability
The plasma fractionation market consists of a host of market players. These include: CSL Behring, Shire plc, Sanquin, Biotest AG, GRIFOLS, Baxter International Inc., Kedrion, Octapharma USA Inc. to name a few. Innovative offerings are key growth strategies adopted by market players.
CSL Behring, for instance, markets the Privigen, Carimune, Snadoglobulin and Hizentra solutions. Sanquin produces four types of plasma products using various isolation techniques: coagulation factors, protease inhibitors, immunoglobulins and albumin. The company also offers contract fractionation services.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4806/S
Biotest AG develops, manufactures and markets plasma proteins and biotherapeutic drugs. It leads in the field of plasma collection. Biotest AG presently develops plasma proteins for Primary Immune Deficiency (PID) and various hyperimmune products. Examples of the products offered are Varitect, Cytotect CP and Albiomin.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4806/plasma-fractionation-market
Content Source: https://www.factmr.com/media-release/1576/global-plasma-fractionation-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulins to Capture 2/5th of the Global Plasma Fractionation Market Share Through 2026 here
News-ID: 2270588 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Unit
Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview:
The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,…
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook.
The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is…
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil…
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption.
Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is…
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India.
Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in…
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP).
Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences.
Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for…
